Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICU sedation mode study for nasotracheal intubation after oral cancer forearm flap reconstruction
ChiCTR1800016017Phase 4Recruiting
- Sponsor
- Hospital of Stomatology Wuhan University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam, dexmedetomidine and propofol in mouth cancer (3 arms), sponsored by Hospital of Stomatology Wuhan University. Primary endpoint: C-reactive protein. Started Jun 2018; status: recruiting.
02
Drugs
midazolamdexmedetomidinepropofol
03
Conditions
mouth cancer
Beyond the preview
Go deeper on ChiCTR1800016017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016017.